US5723289A
(en)
*
|
1990-06-11 |
1998-03-03 |
Nexstar Pharmaceuticals, Inc. |
Parallel selex
|
US6030776A
(en)
*
|
1990-06-11 |
2000-02-29 |
Nexstar Pharmaceuticals, Inc. |
Parallel SELEX
|
US20030125270A1
(en)
*
|
2000-12-18 |
2003-07-03 |
Lawrence Blatt |
Enzymatic nucleic acid treatment of diseases or conditions related to hepatitis C virus infection
|
US20040127446A1
(en)
*
|
1992-05-14 |
2004-07-01 |
Lawrence Blatt |
Oligonucleotide mediated inhibition of hepatitis B virus and hepatitis C virus replication
|
US20070160581A1
(en)
*
|
1994-04-29 |
2007-07-12 |
Cytogenix, Inc. |
Production of ssDNA in vivo
|
US6048698A
(en)
*
|
1994-09-20 |
2000-04-11 |
Nexstar Pharmaceuticals, Inc. |
Parallel SELEX™
|
GB9519299D0
(en)
*
|
1995-09-21 |
1995-11-22 |
Farrar Gwyneth J |
Genetic strategy
|
US20040220128A1
(en)
*
|
1995-10-26 |
2004-11-04 |
Sirna Therapeutics, Inc. |
Nucleic acid based modulation of female reproductive diseases and conditions
|
US20040142895A1
(en)
*
|
1995-10-26 |
2004-07-22 |
Sirna Therapeutics, Inc. |
Nucleic acid-based modulation of gene expression in the vascular endothelial growth factor pathway
|
US20040102389A1
(en)
*
|
1995-10-26 |
2004-05-27 |
Ribozyme Pharmaceuticals, Inc. |
Nucleic acid-mediated treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)
|
US20030069195A1
(en)
*
|
1996-03-01 |
2003-04-10 |
Farrar Gwenyth Jane |
Suppression of polymorphic alleles
|
US20040234999A1
(en)
*
|
1996-04-02 |
2004-11-25 |
Farrar Gwenyth Jane |
Genetic suppression and replacement
|
US8551970B2
(en)
|
1996-04-02 |
2013-10-08 |
Optigen Patents Limited |
Genetic suppression and replacement
|
GB9606961D0
(en)
*
|
1996-04-02 |
1996-06-05 |
Farrar Gwyneth J |
Genetic strategy III
|
GB9608540D0
(en)
*
|
1996-04-25 |
1996-07-03 |
Medical Res Council |
Isolation of enzymes
|
ATE253128T1
(de)
*
|
1996-08-26 |
2003-11-15 |
Genetico Ltd |
Katalytische nukleinsäuren und deren medizinische verwendung
|
EP0958303A4
(en)
*
|
1996-12-19 |
2004-03-31 |
Univ Yale |
BIOREACTIVE ALLOSTERIC POLYNUCLEOTIDES
|
US6057156A
(en)
*
|
1997-01-31 |
2000-05-02 |
Robozyme Pharmaceuticals, Inc. |
Enzymatic nucleic acid treatment of diseases or conditions related to levels of epidermal growth factor receptors
|
IL120714A0
(en)
*
|
1997-04-21 |
1997-08-14 |
Intelligene Ltd |
Continuous in vitro evolution of oligonucleotides
|
AU735522C
(en)
*
|
1997-04-29 |
2005-04-07 |
Scripps Research Institute, The |
Enzymatic dna molecules
|
WO1999016871A2
(en)
*
|
1997-09-22 |
1999-04-08 |
Max-Planck-Gesellschaft Zur Forderung Der Wissensc |
Nucleic acid catalysts with endonuclease activity
|
JP4318856B2
(ja)
*
|
1998-03-05 |
2009-08-26 |
ジョンソン・アンド・ジョンソン・リサーチ・ピー・ティー・ワイ・リミテッド |
チモーゲン性核酸検出方法、および関連分子およびキット
|
ATE431852T1
(de)
*
|
1998-03-27 |
2009-06-15 |
Johnson & Johnson Res Pty Ltd |
Diagnostische methoden basierend auf katalytischen nukleinsäuren
|
CA2326823A1
(en)
|
1998-04-20 |
1999-10-28 |
Ribozyme Pharmaceuticals, Inc. |
Nucleic acid molecules with novel chemical compositions capable of modulating gene expression
|
US6525185B1
(en)
|
1998-05-07 |
2003-02-25 |
Affymetrix, Inc. |
Polymorphisms associated with hypertension
|
AU5298699A
(en)
*
|
1998-08-13 |
2000-03-06 |
Johnson & Johnson Research Pty. Limited |
Dnazymes and methods for treating hpv-related disorders
|
AU5298499A
(en)
*
|
1998-08-13 |
2000-03-06 |
Johnson & Johnson Research Pty. Limited |
Dnazymes and methods for treating restenosis
|
BR9914465A
(pt)
|
1998-09-29 |
2001-10-09 |
Gamida Cell Ltd |
Métodos para controlar a proliferação e a diferenciação de células-tronco e células progenitoras e uma composição farmacêutica para induzir a diferenciação em uma população de células
|
AUPP810399A0
(en)
*
|
1999-01-11 |
1999-02-04 |
Unisearch Limited |
Catalytic molecules
|
US20040235107A1
(en)
*
|
1999-01-29 |
2004-11-25 |
Ramot At Tel Aviv University Ltd. |
Biosynthesis of TA antibiotic
|
DE19915141C2
(de)
*
|
1999-03-26 |
2002-11-21 |
Artus Ges Fuer Molekularbiolog |
Detektion von Nucleinsäure-Amplifikaten
|
AU778737B2
(en)
*
|
1999-04-14 |
2004-12-16 |
Musc Foundation For Research Development |
Tissue-specific and pathogen-specific toxic agents and ribozymes
|
IL130606A0
(en)
*
|
1999-06-23 |
2000-06-01 |
Intelligene Ltd |
An array of nucleic acid sequence
|
AUPQ201499A0
(en)
*
|
1999-08-04 |
1999-08-26 |
Unisearch Limited |
Treatment of inflammatory and malignant diseases
|
US7332275B2
(en)
|
1999-10-13 |
2008-02-19 |
Sequenom, Inc. |
Methods for detecting methylated nucleotides
|
AUPQ367699A0
(en)
*
|
1999-10-26 |
1999-11-18 |
Unisearch Limited |
Treatment of cancer
|
US6613516B1
(en)
*
|
1999-10-30 |
2003-09-02 |
Affymetrix, Inc. |
Preparation of nucleic acid samples
|
AU2625201A
(en)
*
|
2000-01-03 |
2001-07-16 |
Ramot University Authority For Applied Research And Industrial Development Ltd. |
Glycogen synthase kinase-3 inhibitors
|
AU4329001A
(en)
*
|
2000-02-24 |
2001-09-03 |
Compound Therapeutics, Inc. |
Improved methods for generating catalytic proteins
|
US20040009510A1
(en)
*
|
2000-03-06 |
2004-01-15 |
Scott Seiwert |
Allosteric nucleic acid sensor molecules
|
US20020102694A1
(en)
*
|
2000-03-31 |
2002-08-01 |
Ronald Breaker |
Nucleozymes with endonuclease activity
|
EP1702983A3
(en)
|
2000-04-13 |
2007-01-10 |
Medical University of South Carolina |
Tissue-specific and pathogen-specific toxic agents, ribozymes, DNAzymes and antisense oligonucleotides and methods of use thereof
|
US6706474B1
(en)
*
|
2000-06-27 |
2004-03-16 |
Board Of Trustees Of The University Of Illinois |
Nucleic acid enzyme biosensors for ions
|
US20040037828A1
(en)
|
2002-07-09 |
2004-02-26 |
Bar-Ilan University |
Methods and pharmaceutical compositions for healing wounds
|
US20030114410A1
(en)
|
2000-08-08 |
2003-06-19 |
Technion Research And Development Foundation Ltd. |
Pharmaceutical compositions and methods useful for modulating angiogenesis and inhibiting metastasis and tumor fibrosis
|
US8568766B2
(en)
|
2000-08-24 |
2013-10-29 |
Gattadahalli M. Anantharamaiah |
Peptides and peptide mimetics to treat pathologies associated with eye disease
|
EP2322648A1
(en)
|
2000-09-26 |
2011-05-18 |
Duke University |
RNA aptamers and methods for identifying the same
|
JP5305553B2
(ja)
|
2000-10-12 |
2013-10-02 |
ユニバーシティー オブ ロチェスター |
癌細胞の増殖を阻害する組成物
|
CA2442092A1
(en)
*
|
2001-03-26 |
2002-10-17 |
Ribozyme Pharmaceuticals, Inc. |
Oligonucleotide mediated inhibition of hepatitis b virus and hepatitis c virus replication
|
US20040063922A1
(en)
*
|
2001-04-17 |
2004-04-01 |
Conrad Charles A. |
Methods and compositions for catalytic DNA exchange in a sequence specific manner
|
US20040006035A1
(en)
*
|
2001-05-29 |
2004-01-08 |
Dennis Macejak |
Nucleic acid mediated disruption of HIV fusogenic peptide interactions
|
US20050288242A1
(en)
*
|
2001-05-18 |
2005-12-29 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of RAS gene expression using short interfering nucleic acid (siNA)
|
US20050080031A1
(en)
*
|
2001-05-18 |
2005-04-14 |
Sirna Therapeutics, Inc. |
Nucleic acid treatment of diseases or conditions related to levels of Ras, HER2 and HIV
|
WO2002097114A2
(en)
*
|
2001-05-29 |
2002-12-05 |
Sirna Therapeutics, Inc. |
Nucleic acid treatment of diseases or conditions related to levels of ras, her2 and hiv
|
US20050267058A1
(en)
*
|
2001-05-18 |
2005-12-01 |
Sirna Therapeutics, Inc. |
RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (sINA)
|
US20040198682A1
(en)
*
|
2001-11-30 |
2004-10-07 |
Mcswiggen James |
RNA interference mediated inhibition of placental growth factor gene expression using short interfering nucleic acid (siNA)
|
DK2070939T3
(da)
*
|
2001-05-25 |
2014-06-23 |
Univ Duke |
Modulatorer af farmakologiske midler
|
US7378432B2
(en)
*
|
2001-09-14 |
2008-05-27 |
Tel Aviv University Future Technology Development L.P. |
Glycogen synthase kinase-3 inhibitors
|
US7179907B2
(en)
|
2001-12-18 |
2007-02-20 |
Bruce Eaton |
Antibiotic compounds
|
IL152904A0
(en)
|
2002-01-24 |
2003-06-24 |
Gamida Cell Ltd |
Utilization of retinoid and vitamin d receptor antagonists for expansion of renewable stem cell populations
|
EP1465982A4
(en)
|
2002-01-25 |
2006-06-07 |
Gamida Cell Ltd |
PROCESS FOR EXPANSION OF STEM AND PRESERVATIVE CELLS AND EXPANDED CELL POPULATIONS THEREWITH OBTAINED
|
US20040052928A1
(en)
*
|
2002-09-06 |
2004-03-18 |
Ehud Gazit |
Peptides and methods using same for diagnosing and treating amyloid-associated diseases
|
US7781396B2
(en)
|
2002-01-31 |
2010-08-24 |
Tel Aviv University Future Technology Development L.P. |
Peptides directed for diagnosis and treatment of amyloid-associated disease
|
CN1856504B
(zh)
|
2002-02-06 |
2010-12-29 |
史戴西思技术有限公司 |
抗梗塞分子
|
US20050042632A1
(en)
*
|
2002-02-13 |
2005-02-24 |
Sirna Therapeutics, Inc. |
Antibodies having specificity for nucleic acids
|
US7071311B2
(en)
*
|
2002-02-13 |
2006-07-04 |
Sirna Therapeutics, Inc. |
Antibodies having specificity for 2′-C-allyl nucleic acids
|
JP2005517409A
(ja)
|
2002-02-15 |
2005-06-16 |
マクマスター ユニヴァーシティー |
デオキシリボザイム
|
WO2003106476A1
(en)
*
|
2002-02-20 |
2003-12-24 |
Sirna Therapeutics, Inc |
Nucleic acid mediated inhibition of enterococcus infection and cytolysin toxin activity
|
WO2003080804A2
(en)
*
|
2002-03-18 |
2003-10-02 |
The Government Of The United States Of America, Asrepresented By The Secretary, Department Of Health And Human Services, National Institutes Of Health |
Regulation of ins(3456)p4 signalling by a reversible kinase/phosphatase and methods and compositions related thereto
|
US7534560B2
(en)
*
|
2002-05-10 |
2009-05-19 |
The Board Of Trustees Of The University Of Illinois |
Simple catalytic DNA biosensors for ions based on color changes
|
US6890719B2
(en)
*
|
2002-05-10 |
2005-05-10 |
The Board Of Trustess Of The University Of Illinois |
Fluorescence based biosensor
|
US20030224435A1
(en)
*
|
2002-05-16 |
2003-12-04 |
Scott Seiwert |
Detection of abused substances and their metabolites using nucleic acid sensor molecules
|
US20050221326A1
(en)
*
|
2002-06-12 |
2005-10-06 |
Avi Orr-Urtreger |
Oligonucleotides antibodies and kits including same for treating prostate cancer and determining predisposition thereto
|
EP1539245A2
(en)
*
|
2002-06-26 |
2005-06-15 |
The Penn State Research Foundation |
Methods and materials for treating human papillomavirus infections
|
WO2004011680A1
(en)
|
2002-07-25 |
2004-02-05 |
Archemix Corp. |
Regulated aptamer therapeutics
|
EP1575992A4
(en)
|
2002-08-05 |
2007-02-21 |
Univ Rochester |
CHIMERIC PROTEINS WITH PROTEIN TRANSDUCTION FIELD / DOMAINE DESAMINASE, ASSOCIATED COMPOUNDS AND CORRESPONDING USES
|
EP1546170A4
(en)
*
|
2002-09-20 |
2007-08-29 |
Univ Yale |
RIBOSWITCHS, METHODS OF USE, AND COMPOSITIONS FOR USE WITH RIBOSWITCHES
|
US20040147469A1
(en)
*
|
2002-11-01 |
2004-07-29 |
Case Western Reserve University |
Methods of inhibiting glial scar formation
|
AU2003298733B2
(en)
|
2002-11-27 |
2009-06-18 |
Agena Bioscience, Inc. |
Fragmentation-based methods and systems for sequence variation detection and discovery
|
US7491699B2
(en)
*
|
2002-12-09 |
2009-02-17 |
Ramot At Tel Aviv University Ltd. |
Peptide nanostructures and methods of generating and using the same
|
KR20050091716A
(ko)
|
2002-12-12 |
2005-09-15 |
텔 아비브 유니버시티 퓨쳐 테크놀로지 디벨롭먼트 엘.피. |
글리코겐 신타제 키나제-3 억제제
|
DE602004020179D1
(de)
|
2003-01-07 |
2009-05-07 |
Univ Ramot |
Peptidenanostrukturen die fremdmaterial enthalten, und verfahren zur herstellung derselben
|
EP1587482A4
(en)
*
|
2003-01-31 |
2010-08-25 |
Technion Res & Dev Foundation |
ANTI-INFLAMMATORY COMPOSITIONS AND USES THEREOF
|
US7786279B2
(en)
|
2003-02-27 |
2010-08-31 |
Yeda Research And Development Co. Ltd. |
Nucleic acid molecules, polypeptides, antibodies and compositions for treating and detecting influenza virus infection
|
US7612185B2
(en)
*
|
2003-03-07 |
2009-11-03 |
The Board Of Trustees Of The University Of Illinois |
Nucleic acid biosensors
|
WO2004079325A2
(en)
*
|
2003-03-07 |
2004-09-16 |
Mcmaster University |
Ph dependent signaling dna enzymes
|
US20050020526A1
(en)
*
|
2003-06-03 |
2005-01-27 |
Cytogenix, Inc. |
Oligodeoxynucleotide intervention for prevention and treatment of sepsis
|
US20040248101A1
(en)
*
|
2003-06-03 |
2004-12-09 |
Cytogenix, Inc. |
Identification of novel antibacteria agents by screening the single-stranded DNA expression library
|
EP1636333A4
(en)
*
|
2003-06-19 |
2007-10-24 |
Evogene Ltd |
NUCLEOTIDE SEQUENCES FOR REGULATING GENE EXPRESSION IN VEGETABLE TRICHROMES, AND HYBRID GENES AND METHODS IN WHICH THEY INTERVENE
|
US8129514B2
(en)
|
2003-06-19 |
2012-03-06 |
Evogene Ltd. |
Nucleotide sequences for regulating gene expression in plant trichomes and constructs and methods utilizing same
|
IL161903A0
(en)
*
|
2003-07-17 |
2005-11-20 |
Gamida Cell Ltd |
Ex vivo progenitor and stem cell expansion for usein the treatment of disease of endodermally- deri ved organs
|
US20050042212A1
(en)
*
|
2003-07-24 |
2005-02-24 |
Nanda Steven A. |
Method of reducing CRF receptor mRNA
|
US9394565B2
(en)
|
2003-09-05 |
2016-07-19 |
Agena Bioscience, Inc. |
Allele-specific sequence variation analysis
|
WO2005027901A1
(en)
*
|
2003-09-25 |
2005-03-31 |
Tel Aviv University Future Technology Development L.P. |
Compositions and methods using same for treating amyloid-associated diseases
|
US7625707B2
(en)
*
|
2003-10-02 |
2009-12-01 |
Ramot At Tel Aviv University Ltd. |
Antibacterial agents and methods of identifying and utilizing same
|
IL158599A0
(en)
*
|
2003-10-26 |
2004-05-12 |
Yeda Res & Dev |
Methods of modulating hematopoiesis
|
US7485419B2
(en)
*
|
2004-01-13 |
2009-02-03 |
The Board Of Trustees Of The University Of Illinois |
Biosensors based on directed assembly of particles
|
GB0402249D0
(en)
|
2004-02-02 |
2004-03-03 |
Idi Technologies Ltd |
Brush
|
WO2005078848A2
(en)
*
|
2004-02-11 |
2005-08-25 |
University Of Tennessee Research Foundation |
Inhibition of tumor growth and invasion by anti-matrix metalloproteinase dnazymes
|
EP1727911B1
(en)
|
2004-03-26 |
2013-01-23 |
Sequenom, Inc. |
Base specific cleavage of methylation-specific amplification products in combination with mass analysis
|
SG152262A1
(en)
*
|
2004-04-22 |
2009-05-29 |
Regado Biosciences Inc |
Improved modulators of coagulation factors
|
WO2006013552A2
(en)
|
2004-08-02 |
2006-02-09 |
Ramot At Tel Aviv University Ltd. |
Articles of peptide nanostructures and method of forming the same
|
ATE539745T1
(de)
|
2004-08-19 |
2012-01-15 |
Univ Tel Aviv Future Tech Dev |
Zusammensetzungen zur behandlung von amyloid- assoziierten erkrankungen
|
US7786086B2
(en)
*
|
2004-09-08 |
2010-08-31 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructures containing end-capping modified peptides and methods of generating and using the same
|
WO2006030442A2
(en)
|
2004-09-16 |
2006-03-23 |
Gamida-Cell Ltd. |
Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells
|
US20060094026A1
(en)
*
|
2004-11-03 |
2006-05-04 |
Yi Lu |
Nucleic acid enzyme light-up sensor utilizing invasive DNA
|
WO2006055292A2
(en)
*
|
2004-11-04 |
2006-05-26 |
University Of Medicine And Dentistry Of New Jersey |
Single protein production in living cells facilitated by a messenger rna interferase
|
EP1843819A2
(en)
*
|
2004-11-15 |
2007-10-17 |
Obe Therapy Biotechnology S.A.S. |
Methods of reducing body fat
|
US20060166222A1
(en)
*
|
2005-01-21 |
2006-07-27 |
Yi Lu |
Nucleic acid enzyme ligation sensor
|
EP1846034A4
(en)
|
2005-02-02 |
2010-11-10 |
Uab Research Foundation |
AGENTS AND METHODS OF REDUCING THE RESISTANCE TO APOPTOSIS INDUCING DEATH RECEPTOR AGONISTS
|
IL296666A
(en)
|
2005-03-23 |
2022-11-01 |
Genmab As |
Antibodies against 38cd for the treatment of multiple myeloma
|
US20070072205A1
(en)
*
|
2005-06-09 |
2007-03-29 |
Yi Lu |
Nanomaterial error correction
|
US20070225242A1
(en)
*
|
2005-06-21 |
2007-09-27 |
The Board Of Trustees Of The Leland Stanford Junior University |
Method and composition for treating and preventing tumor metastasis in vivo
|
ES2435774T3
(es)
|
2005-07-07 |
2013-12-23 |
Yissum Research Development Company, Of The Hebrew University Of Jerusalem |
Agentes de ácido nucleico para la regulación negativa de H19, y métodos de uso del mismo
|
WO2007014469A1
(en)
*
|
2005-08-01 |
2007-02-08 |
Chu Sainte-Justine, Le Centre Hospitalier Universitaire Mere-Enfant |
Hepatitis c antivirals
|
US7892734B2
(en)
*
|
2005-08-11 |
2011-02-22 |
The Board Of Trustees Of The University Of Illinois |
Aptamer based colorimetric sensor systems
|
EP2578685B1
(en)
|
2005-08-23 |
2019-04-17 |
The Trustees Of The University Of Pennsylvania |
Rna containing modified nucleosides and methods of use thereof
|
US20100255026A1
(en)
*
|
2005-10-06 |
2010-10-07 |
Michael Jason Stump |
Methods and compositions relating to anthrax spore glycoproteins as vaccines
|
DK2385141T3
(da)
*
|
2005-10-07 |
2013-10-28 |
Speedx Pty Ltd |
Flerkomponentnukleinsyreenzymer og fremgangsmåder til anvendelse heraf
|
EP1973928A2
(en)
|
2005-10-11 |
2008-10-01 |
Ramot at Tel-Aviv University Ltd. |
Self-assembled fmoc-ff hydrogels
|
WO2007043049A1
(en)
*
|
2005-10-11 |
2007-04-19 |
Ben-Gurion University Of The Negev Research And Development Authority |
Compositions for silencing the expression of vdac1 and uses thereof
|
EP2392645A1
(en)
|
2005-10-14 |
2011-12-07 |
MUSC Foundation For Research Development |
Targeting PAX2 for the induction of DEFB1-mediated tumor immunity and cancer therapy
|
US8080534B2
(en)
|
2005-10-14 |
2011-12-20 |
Phigenix, Inc |
Targeting PAX2 for the treatment of breast cancer
|
US7879212B2
(en)
*
|
2005-11-03 |
2011-02-01 |
Ramot At Tel-Aviv University Ltd. |
Peptide nanostructure-coated electrodes
|
US8846393B2
(en)
|
2005-11-29 |
2014-09-30 |
Gamida-Cell Ltd. |
Methods of improving stem cell homing and engraftment
|
EP1974052A2
(en)
*
|
2005-12-21 |
2008-10-01 |
Yale University |
Methods and compositions related to the modulation of riboswitches
|
CN100562342C
(zh)
*
|
2006-01-17 |
2009-11-25 |
奥林格斯技术有限公司 |
防治流感病毒感染的寡核苷酸药物
|
WO2007109500A1
(en)
*
|
2006-03-16 |
2007-09-27 |
The Board Of Trustees Of The University Of Illinois |
Lateral flow devices
|
US8097596B2
(en)
*
|
2006-06-30 |
2012-01-17 |
Lakewood-Amedex, Inc. |
Compositions and methods for the treatment of muscle wasting
|
US20100137440A1
(en)
*
|
2006-09-11 |
2010-06-03 |
Yale University |
Lysine riboswitches, structure-based compound design with lysine riboswitches, and methods and compositions for use of and with lysine riboswitches
|
JP5926475B2
(ja)
|
2006-09-21 |
2016-05-25 |
ユニバーシティー オブ ロチェスター |
筋緊張性ジストロフィーのためのタンパク質置換治療に関する組成物および方法
|
ZA200901742B
(en)
*
|
2006-10-06 |
2010-06-30 |
Johnson & Johnson Res Pty Ltd |
Moleculor switches and methods for their use
|
US8999317B2
(en)
|
2006-11-01 |
2015-04-07 |
University Of Rochester |
Methods and compositions related to the structure and function of APOBEC3G
|
CA2667971C
(en)
|
2006-11-01 |
2017-04-18 |
Gary Weisinger |
Adipocyte-specific constructs and methods for inhibiting platelet-type 12 lipoxygenase expression
|
US7994130B2
(en)
|
2006-12-11 |
2011-08-09 |
University Of Utah Research Foundation |
Compositions and methods for treating ocular pathologic angiogenesis and vascular permeability
|
US7928083B2
(en)
*
|
2007-01-16 |
2011-04-19 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
H19 silencing nucleic acid agents for treating rheumatoid arthritis
|
US8415461B2
(en)
*
|
2007-01-19 |
2013-04-09 |
The Board Of Trustees Of The University Of Illinois |
Amphiphilic substances and functionalized lipid vesicles including the same
|
WO2008093331A1
(en)
*
|
2007-01-29 |
2008-08-07 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem |
Antibody conjugates for circumventing multi-drug resistance
|
EP2142673B1
(en)
*
|
2007-04-05 |
2013-05-22 |
Johnson & Johnson Research Pty Limited |
Nucleic acid enzymes and complexes and methods for their use
|
US8058415B2
(en)
|
2007-04-24 |
2011-11-15 |
The Board Of Trustees Of The University Of Illinois |
Aptamer- and nucleic acid enzyme-based systems for simultaneous detection of multiple analytes
|
CA2687684A1
(en)
*
|
2007-05-29 |
2008-12-11 |
Yale University |
Methods and compositions related to riboswitches that control alternative splicing and rna processing
|
JP2010528617A
(ja)
*
|
2007-05-29 |
2010-08-26 |
イェール ユニバーシティー |
リボスイッチならびにリボスイッチを使用するためのおよびリボスイッチと共てに使用するための方法および組成物
|
US20100159597A1
(en)
*
|
2007-06-11 |
2010-06-24 |
Dai Nippon Printing Co., Ltd. |
Cell culture membrane, cell culture kit, porous material, production method for cell culture membrane and production method for porous material
|
AU2008277257B2
(en)
|
2007-07-15 |
2014-03-06 |
Hillman, Yitzchak Mr |
Disease treatment via antimicrobial peptides or their inhibitors
|
IL184627A0
(en)
|
2007-07-15 |
2008-12-29 |
Technion Res & Dev Foundation |
Agents for diagnosing and modulating metastasis and fibrosis as well as inflammation in a mammalian tissue
|
WO2009012309A2
(en)
*
|
2007-07-16 |
2009-01-22 |
The Board Of Trustees Of The University Of Illinois |
Nucleic acid based fluorescent sensor for divalent copper ion detection
|
US8568690B2
(en)
*
|
2007-07-31 |
2013-10-29 |
The Board Of Trustees Of The University Of Illinois |
MRI contrast agents and high-throughput screening by MRI
|
CN110372795A
(zh)
|
2007-08-02 |
2019-10-25 |
吉利德生物制剂公司 |
Lox和loxl2抑制剂及其应用
|
US8367416B2
(en)
|
2007-08-10 |
2013-02-05 |
The Board Of Trustees Of The University Of Illinois |
Nucleic acid based fluorescent sensor for mercury detection
|
WO2009026496A1
(en)
*
|
2007-08-22 |
2009-02-26 |
University Of Southern California |
Grp78 and tumor angiogenesis
|
WO2009032693A2
(en)
|
2007-08-28 |
2009-03-12 |
Uab Research Foundation |
Synthetic apolipoprotein e mimicking polypeptides and methods of use
|
AU2008296487A1
(en)
|
2007-08-28 |
2009-03-12 |
The Uab Research Foundation |
Synthetic apolipoprotein E mimicking polypeptides and methods of use
|
WO2010070380A2
(en)
|
2007-12-03 |
2010-06-24 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health Of Human Services, National Institutes Of Health |
Doc1 compositions and methods for treating cancer
|
US20090233993A1
(en)
*
|
2008-03-06 |
2009-09-17 |
Burnham Institute For Medical Research |
Compositions and methods for inhibiting gsk3 activity and uses thereof
|
WO2009114543A2
(en)
|
2008-03-11 |
2009-09-17 |
Sequenom, Inc. |
Nucleic acid-based tests for prenatal gender determination
|
WO2009137686A1
(en)
|
2008-05-08 |
2009-11-12 |
University Of Utah Research Foundation |
Sensory receptors for chronic fatigue and pain and uses thereof
|
US20100105039A1
(en)
*
|
2008-06-03 |
2010-04-29 |
Yi Lu |
Label-free colorimetric detection
|
US8962247B2
(en)
|
2008-09-16 |
2015-02-24 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non invasive prenatal diagnoses
|
US8476013B2
(en)
|
2008-09-16 |
2013-07-02 |
Sequenom, Inc. |
Processes and compositions for methylation-based acid enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US8062893B2
(en)
|
2008-10-10 |
2011-11-22 |
The Board Of Trustees Of The University Of Illinois |
Fluorescent sensor for mercury
|
US20120070443A1
(en)
|
2008-12-02 |
2012-03-22 |
University Of Utah Research Foundation |
Pde1 as a target therapeutic in heart disease
|
EP2808402A3
(en)
|
2008-12-29 |
2015-03-25 |
Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. |
Methods of predicting responsiveness to interferon treatment
|
US9107935B2
(en)
|
2009-01-06 |
2015-08-18 |
Gilead Biologics, Inc. |
Chemotherapeutic methods and compositions
|
US20120020954A1
(en)
|
2009-03-30 |
2012-01-26 |
Anat Achiron |
Methods of predicting clinical course and treating multiple sclerosis
|
JP2012522762A
(ja)
|
2009-04-01 |
2012-09-27 |
ザ メディカル リサーチ, インフラストラクチャー, アンド ヘルス サーヴィシーズ ファンド オブ ザ テル アヴィヴ メディカル センター |
ケラチノサイトの増殖および分化を調節する方法
|
WO2010137020A1
(en)
|
2009-05-28 |
2010-12-02 |
Yeda Research And Development Co. Ltd. |
Methods of treating inflammation
|
WO2011004379A1
(en)
|
2009-07-10 |
2011-01-13 |
Tel Hashomer Medical Research Infrastructure And Services Ltd. |
Compositions and methods for treating cancer
|
BR112012008078A2
(pt)
|
2009-08-21 |
2017-07-04 |
Beeologics Inc |
prevenção e cura de doenças de inseto benéfico por meio de moléculas transcritas de planta.
|
MX2012002272A
(es)
|
2009-08-21 |
2012-07-03 |
Gilead Biologics Inc |
Dominios cataliticos de lisil oxidasa y loxl2.
|
US9610331B2
(en)
|
2009-09-08 |
2017-04-04 |
Yeda Research And Development Co. Ltd. |
Methods for hematopoietic precursor mobilization
|
WO2011031974A1
(en)
|
2009-09-10 |
2011-03-17 |
Southern Research Institute |
Acridine analogs in the treatment of gliomas
|
CA2785020C
(en)
|
2009-12-22 |
2020-08-25 |
Sequenom, Inc. |
Processes and kits for identifying aneuploidy
|
AU2011212830B2
(en)
|
2010-02-04 |
2014-05-22 |
Gilead Biologics, Inc. |
Antibodies that bind to lysyl oxidase-like 2 (LOXL2) and methods of use therefor
|
US20110207789A1
(en)
|
2010-02-19 |
2011-08-25 |
Ye Fang |
Methods related to casein kinase ii (ck2) inhibitors and the use of purinosome-disrupting ck2 inhibitors for anti-cancer therapy agents
|
WO2011107939A1
(en)
|
2010-03-01 |
2011-09-09 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Methods of predicting efficacy of an anti-vegfa treatment for solid tumors
|
WO2011111041A1
(en)
|
2010-03-09 |
2011-09-15 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Organism with altered carotenoid content and method of producing same
|
AU2011243958B2
(en)
|
2010-04-18 |
2015-01-22 |
Yeda Research And Development Co. Ltd. |
Molecules and methods of using same for treating ErbB/ErbB ligands associated diseases
|
EP2582842A2
(en)
|
2010-06-16 |
2013-04-24 |
Yissum Research Development Company of The Hebrew University of Jerusalem |
Method of diagnosing and treating cancer
|
US8815156B2
(en)
|
2010-07-19 |
2014-08-26 |
Andalyze, Inc. |
Sensor housing and reagent chemistry
|
CA2807552A1
(en)
|
2010-08-06 |
2012-02-09 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
EP2614150A1
(en)
|
2010-09-07 |
2013-07-17 |
Yeda Research and Development Co. Ltd. |
Thiamine pyrophosphate (tpp) riboswitch mutants producing vitamin b1 enriched food and feed crops
|
WO2012034130A2
(en)
|
2010-09-10 |
2012-03-15 |
Qiagen |
Methods and compositions for nucleic acid detection
|
CN103210082A
(zh)
|
2010-09-15 |
2013-07-17 |
雷蒙特亚特特拉维夫大学有限公司 |
扩增胰岛β细胞和使其再分化的方法
|
KR20130110170A
(ko)
|
2010-09-22 |
2013-10-08 |
앨리오스 바이오파마 인크. |
치환된 뉴클레오타이드 유사체
|
EP3431485B1
(en)
|
2010-10-01 |
2020-12-30 |
ModernaTX, Inc. |
Engineered nucleic acids and methods of use thereof
|
WO2012052872A2
(en)
|
2010-10-17 |
2012-04-26 |
Yeda Research And Development Co. Ltd. |
Methods and compositions for the treatment of insulin-associated medical conditions
|
WO2012095843A1
(en)
|
2011-01-13 |
2012-07-19 |
Yeda Research And Development Co. Ltd. |
Organisms with altered steroidal saponin and steroidal alkaloid levels and methods for producing same
|
US9243034B2
(en)
|
2011-01-27 |
2016-01-26 |
Ramot At Tel-Aviv University Ltd. |
Glycogen synthase kinase-3 inhibitors
|
US9688719B2
(en)
|
2011-01-27 |
2017-06-27 |
Ramot At Tel-Aviv University Ltd. |
Glycogen synthase kinase-3 inhibitors
|
WO2012135805A2
(en)
|
2011-03-31 |
2012-10-04 |
modeRNA Therapeutics |
Delivery and formulation of engineered nucleic acids
|
EP3378954B1
(en)
|
2011-04-29 |
2021-02-17 |
Sequenom, Inc. |
Quantification of a minority nucleic acid species
|
EP2720720B1
(en)
|
2011-06-14 |
2018-02-28 |
Yeda Research and Development Co. Ltd. |
Combination therapy to prevent dcis formation and progression to breast cancer
|
EP2741753A2
(en)
|
2011-08-09 |
2014-06-18 |
Yeda Research and Development Co. Ltd. |
Downregulation of mir-7 for promotion of beta cell differentiation and insulin production
|
BR112014005505B1
(pt)
*
|
2011-09-09 |
2021-01-12 |
Speedx Pty Ltd. |
substrato de polinucleotídeo isolado para uma enzima de ácido nucleico multi-componente (mnazima) ou dnazima, método para detectar a presença de pelo menos um alvo, kit e montagem
|
US9464124B2
(en)
|
2011-09-12 |
2016-10-11 |
Moderna Therapeutics, Inc. |
Engineered nucleic acids and methods of use thereof
|
AU2012318752B2
(en)
|
2011-10-03 |
2017-08-31 |
Modernatx, Inc. |
Modified nucleosides, nucleotides, and nucleic acids, and uses thereof
|
EP2771464B1
(en)
|
2011-10-27 |
2018-03-21 |
Yeda Research and Development Co. Ltd. |
Methods of treating cancer
|
EP2782930B1
(en)
|
2011-11-27 |
2018-07-11 |
Yeda Research and Development Co. Ltd. |
Methods of regulating angiogenesis and compositions capable of same
|
CN104114572A
(zh)
|
2011-12-16 |
2014-10-22 |
现代治疗公司 |
经修饰的核苷、核苷酸和核酸组合物
|
US8980865B2
(en)
|
2011-12-22 |
2015-03-17 |
Alios Biopharma, Inc. |
Substituted nucleotide analogs
|
US10047345B2
(en)
|
2012-02-13 |
2018-08-14 |
Gamida-Cell Ltd. |
Culturing of mesenchymal stem cells with FGF4 and nicotinamide
|
US9803175B2
(en)
|
2012-02-22 |
2017-10-31 |
Exostem Biotec Ltd. |
Generation of neural stem cells and motor neurons
|
EP3757210B1
(en)
|
2012-03-02 |
2022-08-24 |
Sequenom, Inc. |
Methods for enriching cancer nucleic acid from a biological sample
|
CN104411724B
(zh)
|
2012-03-07 |
2018-08-31 |
耶达研究及发展有限公司 |
抑制静止素巯基氧化酶(qsox1)的组合物及其用途
|
CN104321333A
(zh)
|
2012-03-21 |
2015-01-28 |
沃泰克斯药物股份有限公司 |
硫代氨基磷酸酯核苷酸前药的固体形式
|
NZ630805A
(en)
|
2012-03-22 |
2016-01-29 |
Alios Biopharma Inc |
Pharmaceutical combinations comprising a thionucleotide analog
|
US9283287B2
(en)
|
2012-04-02 |
2016-03-15 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of nuclear proteins
|
US10501512B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides
|
US9572897B2
(en)
|
2012-04-02 |
2017-02-21 |
Modernatx, Inc. |
Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
|
EP2833923A4
(en)
|
2012-04-02 |
2016-02-24 |
Moderna Therapeutics Inc |
MODIFIED POLYNUCLEOTIDES FOR THE PRODUCTION OF PROTEINS
|
US9920361B2
(en)
|
2012-05-21 |
2018-03-20 |
Sequenom, Inc. |
Methods and compositions for analyzing nucleic acid
|
US20140093873A1
(en)
|
2012-07-13 |
2014-04-03 |
Sequenom, Inc. |
Processes and compositions for methylation-based enrichment of fetal nucleic acid from a maternal sample useful for non-invasive prenatal diagnoses
|
US9175266B2
(en)
|
2012-07-23 |
2015-11-03 |
Gamida Cell Ltd. |
Enhancement of natural killer (NK) cell proliferation and activity
|
US9567569B2
(en)
|
2012-07-23 |
2017-02-14 |
Gamida Cell Ltd. |
Methods of culturing and expanding mesenchymal stem cells
|
US9597380B2
(en)
|
2012-11-26 |
2017-03-21 |
Modernatx, Inc. |
Terminally modified RNA
|
AU2013350721A1
(en)
|
2012-11-29 |
2015-01-29 |
Yeda Research And Development Co. Ltd. |
Methods of preventing tumor metastasis, treating and prognosing cancer and identifying agents which are putative metastasis inhibitors
|
EP3597774A1
(en)
|
2013-03-13 |
2020-01-22 |
Sequenom, Inc. |
Primers for dna methylation analysis
|
US20160032316A1
(en)
|
2013-03-14 |
2016-02-04 |
The Trustees Of The University Of Pennsylvania |
Purification and Purity Assessment of RNA Molecules Synthesized with Modified Nucleosides
|
US8980864B2
(en)
|
2013-03-15 |
2015-03-17 |
Moderna Therapeutics, Inc. |
Compositions and methods of altering cholesterol levels
|
RU2015149680A
(ru)
|
2013-04-21 |
2017-05-24 |
Йеда Ресеарч Энд Девелопмент Ко. Лтд. |
Агенты для подавления активности и/или снижения количества bcl-xl и/или bcl-w
|
WO2014195944A1
(en)
|
2013-06-05 |
2014-12-11 |
Yeda Research And Development Co. Ltd. |
Plant with altered content of steroidal glycoalkaloids
|
US10806119B2
(en)
|
2013-06-05 |
2020-10-20 |
Yeda Research And Development Co. Ltd. |
Plant with altered content of steroidal alkaloids
|
EP3013850B1
(en)
|
2013-06-24 |
2018-07-25 |
Ramot at Tel-Aviv University Ltd. |
Glycogen synthase kinase-3 inhibitors
|
MX2015016628A
(es)
|
2013-06-25 |
2016-06-29 |
Inst Medical W & E Hall |
Metodo para tratar infeccion intracelular.
|
WO2015048744A2
(en)
|
2013-09-30 |
2015-04-02 |
Moderna Therapeutics, Inc. |
Polynucleotides encoding immune modulating polypeptides
|
JP2016538829A
(ja)
|
2013-10-03 |
2016-12-15 |
モデルナ セラピューティクス インコーポレイテッドModerna Therapeutics,Inc. |
低密度リポタンパク質受容体をコードするポリヌクレオチド
|
CA2937992A1
(en)
|
2014-02-03 |
2015-08-06 |
Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. |
Method of eliminating stem cells
|
CN106715695B
(zh)
|
2014-02-05 |
2020-07-31 |
耶达研究及发展有限公司 |
用于治疗和诊断的微rna和包含所述微rna的组合物
|
US11365447B2
(en)
|
2014-03-13 |
2022-06-21 |
Sequenom, Inc. |
Methods and processes for non-invasive assessment of genetic variations
|
WO2015186129A1
(en)
|
2014-06-02 |
2015-12-10 |
Technion Research & Development Foundation Limited. |
Compositions and methods of selectively inhibiting irp1 and treating inflammation
|
JP2017525351A
(ja)
|
2014-07-30 |
2017-09-07 |
イェダ リサーチ アンド ディベロップメント カンパニー リミテッドYeda Research And Development Co.Ltd. |
多能性幹細胞の培養用培地
|
CA2954475C
(en)
|
2014-07-31 |
2023-05-16 |
Uab Research Foundation |
Apoe mimetic peptides and higher potency to clear plasma cholesterol
|
WO2016030899A1
(en)
|
2014-08-28 |
2016-03-03 |
Yeda Research And Development Co. Ltd. |
Methods of treating amyotrophic lateral scleroses
|
US20180042994A1
(en)
|
2014-11-17 |
2018-02-15 |
Yeda Research And Development Co. Ltd. |
Methods of treating diseases related to mitochondrial function
|
WO2016079527A1
(en)
|
2014-11-19 |
2016-05-26 |
Tetralogic Birinapant Uk Ltd |
Combination therapy
|
WO2016097773A1
(en)
|
2014-12-19 |
2016-06-23 |
Children's Cancer Institute |
Therapeutic iap antagonists for treating proliferative disorders
|
US20170369556A1
(en)
|
2014-12-23 |
2017-12-28 |
Ralph A. Tripp |
RECOMBINANT CELLS COMPRISING miRNA MIMICS
|
WO2016135716A1
(en)
|
2015-02-26 |
2016-09-01 |
Jacob Schneiderman |
Methods and compositions relating to leptin antagonists
|
EP3261612A1
(en)
|
2015-02-26 |
2018-01-03 |
Yeda Research and Development Co. Ltd |
Method of promoting hair growth
|
EP4005569A3
(en)
|
2015-04-07 |
2022-06-22 |
ELA Pharma Ltd |
Compositions for treating and/or preventing cell or tissue necrosis specifically targeting cathepsin c and/or cela1 and/or cela3a and/or structurally related enzymes thereto
|
EP3294280A1
(en)
|
2015-05-11 |
2018-03-21 |
Yeda Research and Development Co., Ltd. |
Citrin inhibitors for the treatment of cancer
|
WO2016185457A1
(en)
|
2015-05-19 |
2016-11-24 |
Yeda Research And Development Co. Ltd. |
Methods of promoting lymphangiogenesis
|
EP3331546B1
(en)
|
2015-08-03 |
2023-10-04 |
Biokine Therapeutics Ltd. |
Cxcr4 inhibitor for the treatment of cancer
|
US11174484B2
(en)
|
2015-11-10 |
2021-11-16 |
B. G. Negev Technologies And Applications Ltd., At Ben- Gurion University |
Means and methods for reducing tumorigenicity of cancer stem cells
|
EP3400068A1
(en)
|
2016-01-06 |
2018-11-14 |
Yeda Research and Development Co., Ltd. |
Compositions and methods for treating malignant, autoimmune and inflammatory diseases
|
WO2017153982A1
(en)
|
2016-03-06 |
2017-09-14 |
Yeda Research And Development Co. Ltd. |
Method for modulating myelination
|
EP3436076A1
(en)
|
2016-03-30 |
2019-02-06 |
Regentis Biomaterials Ltd. |
Treatments utilizing a polymer-protein conjugate
|
EP3950941A3
(en)
*
|
2016-07-13 |
2022-04-20 |
Novozymes A/S |
Dnase polypeptide variants
|
JP2019524787A
(ja)
|
2016-08-03 |
2019-09-05 |
エイチ リー モフィット キャンサー センター アンド リサーチ インスティテュート インコーポレイテッド |
Tlr9標的治療薬
|
IL247368A0
(en)
|
2016-08-18 |
2016-11-30 |
Yeda Res & Dev |
Diagnostic and therapeutic uses of exosomes
|
IL250538A0
(en)
|
2017-02-09 |
2017-03-30 |
Yeda Res & Dev |
Metabolizing glycoalkaloid enzymes (games) and their uses
|
WO2018232357A1
(en)
|
2017-06-15 |
2018-12-20 |
Modernatx, Inc. |
Rna formulations
|
CA3066767A1
(en)
|
2017-06-30 |
2019-01-03 |
Codexis, Inc. |
T7 rna polymerase variants
|
CN111032863A
(zh)
|
2017-06-30 |
2020-04-17 |
科德克希思公司 |
T7 rna聚合酶变体
|
US11555192B2
(en)
|
2017-07-27 |
2023-01-17 |
The National Institute for Biotechnology in the Negev Ltd. |
SMAC/Diablo inhibitors useful for treating cancer
|
JP7275111B2
(ja)
|
2017-08-31 |
2023-05-17 |
モデルナティエックス インコーポレイテッド |
脂質ナノ粒子の生成方法
|
IL255664A0
(en)
|
2017-11-14 |
2017-12-31 |
Shachar Idit |
Hematopoietic stem cells with enhanced properties
|
US20220217934A1
(en)
|
2018-09-06 |
2022-07-14 |
Yeda Research And Development Co. Ltd. |
Cellulose-synthase-like enzymes and uses thereof
|
IL265841A
(en)
|
2019-04-03 |
2020-10-28 |
Yeda Res & Dev |
A plant that expresses animal milk proteins
|
CA3147575A1
(en)
|
2019-07-29 |
2021-02-04 |
Yeda Research And Development Co. Ltd. |
Methods of treating and diagnosing lung cancer
|
WO2022144882A2
(en)
|
2020-12-28 |
2022-07-07 |
1E Therapeutics, Ltd. |
P21 mrna target areas for silencing
|
KR20230133859A
(ko)
*
|
2020-12-28 |
2023-09-19 |
1이 테라퓨틱스 엘티디. |
p21 mRNA 표적화 DNA자임
|